Condition
Chronic Kidney Disease, Stage 3 (Moderate)
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed3
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04087798Not ApplicableCompleted
Controlling Hypertension Through Education and Coaching in Kidney Disease
NCT04960514Active Not Recruiting
Prospective Decision Impact Trial of KidneyIntelX
NCT04827290Not ApplicableNot Yet Recruiting
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
NCT03795389Phase 1Completed
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
NCT03472105Not ApplicableCompletedPrimary
Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4
Showing all 5 trials